Invex Therapeutics Ltd (IXC.AX)
AUD 0.07
(0.0%)
AUD 0.07
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 6.12 Million AUD | -73.16% |
| 2023 | 22.8 Million AUD | -22.66% |
| 2022 | 29.48 Million AUD | -9.93% |
| 2021 | 32.73 Million AUD | 23.92% |
| 2020 | 26.41 Million AUD | 113.49% |
| 2019 | 12.37 Million AUD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 FY | 6.12 Million AUD | -73.16% |
| 2024 Q2 | 6.28 Million AUD | 0.0% |
| 2024 Q4 | 6.12 Million AUD | 0.0% |
| 2023 Q1 | 25.89 Million AUD | -12.17% |
| 2023 Q4 | 22.8 Million AUD | 0.0% |
| 2023 Q2 | 25.89 Million AUD | 0.0% |
| 2023 Q3 | 22.8 Million AUD | -11.94% |
| 2023 FY | 22.8 Million AUD | -22.66% |
| 2022 FY | 29.48 Million AUD | -9.93% |
| 2022 Q4 | 29.48 Million AUD | 0.0% |
| 2022 Q3 | 29.48 Million AUD | -6.43% |
| 2022 Q2 | 31.51 Million AUD | 0.0% |
| 2022 Q1 | 31.51 Million AUD | -3.75% |
| 2021 Q1 | 33.65 Million AUD | 27.4% |
| 2021 FY | 32.73 Million AUD | 23.92% |
| 2021 Q4 | 32.73 Million AUD | 0.0% |
| 2021 Q3 | 32.73 Million AUD | -2.73% |
| 2021 Q2 | 33.65 Million AUD | 0.0% |
| 2020 Q3 | 26.41 Million AUD | 140.25% |
| 2020 Q2 | 10.99 Million AUD | 0.0% |
| 2020 Q1 | 10.99 Million AUD | 0.0% |
| 2020 FY | 26.41 Million AUD | 113.49% |
| 2020 Q4 | 26.41 Million AUD | 0.0% |
| 2019 FY | 12.37 Million AUD | 0.0% |
| 2019 Q3 | 638.2 Thousand AUD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| AdAlta Limited | 5.57 Million AUD | -9.816% |
| Acrux Limited | 8.96 Million AUD | 31.719% |
| Actinogen Medical Limited | 21.31 Million AUD | 71.283% |
| AnteoTech Limited | 9.38 Million AUD | 34.762% |
| Argenica Therapeutics Limited | 16.37 Million AUD | 62.631% |
| Arovella Therapeutics Limited | 13.28 Million AUD | 53.932% |
| Anatara Lifesciences Ltd | 1.67 Million AUD | -266.158% |
| Alterity Therapeutics Limited | 19.22 Million AUD | 68.164% |
| Amplia Therapeutics Limited | 14.84 Million AUD | 58.774% |
| Avecho Biotechnology Limited | 7.31 Million AUD | 16.385% |
| Bio-Gene Technology Limited | 3.15 Million AUD | -93.698% |
| Biome Australia Limited | 8.27 Million AUD | 26.058% |
| Biotron Limited | 493.47 Thousand AUD | -1140.192% |
| Botanix Pharmaceuticals Limited | 112.46 Million AUD | 94.558% |
| BTC Health Limited | 5.14 Million AUD | -18.863% |
| Chimeric Therapeutics Limited | 15.27 Million AUD | 59.929% |
| CSL Limited | 56.93 Billion AUD | 99.989% |
| Clarity Pharmaceuticals Ltd | 154.62 Million AUD | 96.042% |
| Clinuvel Pharmaceuticals Limited | 231.12 Million AUD | 97.352% |
| Cynata Therapeutics Limited | 8.38 Million AUD | 27.041% |
| Dimerix Limited | 32.07 Million AUD | 80.922% |
| EZZ Life Science Holdings Limited | 25.55 Million AUD | 76.049% |
| Hexima Limited | 2.26 Million AUD | -169.724% |
| Island Pharmaceuticals Limited | 2.56 Million AUD | -138.648% |
| Immuron Limited | 15.54 Million AUD | 60.643% |
| Immutep Limited | 147.44 Million AUD | 95.849% |
| Imugene Limited | 151.39 Million AUD | 95.958% |
| Memphasys Limited | 12.43 Million AUD | 50.764% |
| Nanollose Limited | 241.95 Thousand AUD | -2429.459% |
| Neuren Pharmaceuticals Limited | 247.97 Million AUD | 97.532% |
| Noxopharm Limited | 6.78 Million AUD | 9.784% |
| NeuroScientific Biopharmaceuticals Limited | 5.43 Million AUD | -12.586% |
| Nyrada Inc. | 5.9 Million AUD | -3.602% |
| Orthocell Limited | 26.61 Million AUD | 77.005% |
| PharmAust Limited | 11.12 Million AUD | 44.988% |
| Patrys Limited | 4.16 Million AUD | -47.061% |
| Paradigm Biopharmaceuticals Limited | 27.39 Million AUD | 77.656% |
| Proteomics International Laboratories Limited | 10.87 Million AUD | 43.724% |
| Prescient Therapeutics Limited | 20.39 Million AUD | 69.989% |
| PYC Therapeutics Limited | 91.23 Million AUD | 93.292% |
| Race Oncology Limited | 20.22 Million AUD | 69.746% |
| Radiopharm Theranostics Limited | 72.03 Million AUD | 91.504% |
| Recce Pharmaceuticals Ltd | 6.36 Million AUD | 3.918% |
| Starpharma Holdings Limited | 36.81 Million AUD | 83.376% |
| Telix Pharmaceuticals Limited | 398.3 Million AUD | 98.463% |
| Tissue Repair Ltd | 19.38 Million AUD | 68.436% |
| Zelira Therapeutics Limited | 5.18 Million AUD | -18.07% |